Rheumatoid arthritis (RA) is a debilitating autoimmune disease that requires ongoing treatment to manage inflammation, pain and joint damage. For many patients, biologic infusions such as Remicade, Actemra, and Orencia are essential. but they come at an enormous cost, often due not just to the drug itself but also to the site of service.
Why Are RA Infusions So Expensive?
The cost of an RA infusion can vary drastically based on where it’s administered:
And the impact is significant:
For employers, these inflated costs aren’t just a burden—they’re avoidable.
How Leap Health Saves Employers $24,000 Per RA Patient
Leap Health eliminates unnecessary markups through pass-through pricing, ensuring that employers and patients pay only the true drug cost. With Leap:
Average employer savings per patient = $3,500 per treatment / $24,000 annually
The Bottom Line
RA patients shouldn’t have to navigate financial roadblocks just to stay mobile and pain-free. With Leap Health, infusion therapy is both affordable and accessible—helping employers save millions while ensuring their employees receive the care they need.
Contact Leap Health today to learn how much you could save.